May. 12 at 11:39 PM
$TVGN Don’t fear the dilution—EMBRACE it! 🚀 Here is why:
-- Using shares to close the CRO, Apozeal, and Clinicus deals is a brilliant move. These shares create value, not dilution (not only helps Market Cap to become more than
$50 million, but also creates value and business/revenue).
-- It’s NOT just about Nasdaq Compliance; it’s about VALUE EXPLOSION. When you dilute to acquire
$20M+ in immediate revenue and FDA-approved assets, the 'Intrinsic Value' of the company grows faster than the share count.
-- This is how small-caps evolve into giants. 📈We’re hitting the
$50M Market Cap requirement through REAL growth, not just hype.
-- Institutional investors will flood in once they see the revenue on the books. The Patel Family is securing the 51% because they know
$8 is just the starting block. 🌕♟️
NFA, please do your own DD. Best regards!
